Cargando…
Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control
Long-term elite controllers (LTECs) are a fascinating small subset of HIV individuals with viral and immunological HIV control in the long term that have been designated as models of an HIV functional cure. However, data on the LTEC phenotype are still scarce, and hence, the metabolomics and lipidom...
Autores principales: | Masip, Jenifer, Rallón, Norma, Yeregui, Elena, Olona, Montserrat, Resino, Salvador, Benito, José M., Viladés, Consuelo, García-Pardo, Graciano, Alcamí, José, Ruiz-Mateos, Ezequiel, Gómez-Bertomeu, Frederic, Vargas, Montserrat, Navarro, Marta, Oteo, José A., Pineda, Juan A., Martí, Anna, Alba, Verónica, Vidal, Francesc, Peraire, Joaquin, Rull, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065415/ https://www.ncbi.nlm.nih.gov/pubmed/35514981 http://dx.doi.org/10.3389/fimmu.2022.822272 |
Ejemplares similares
-
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
por: Yeregui, Elena, et al.
Publicado: (2022) -
Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation
por: Masip, Jenifer, et al.
Publicado: (2022) -
Differential miRNA plasma profiles associated with the spontaneous loss of HIV‐1 control: miR‐199a‐3p and its potential role as a biomarker for quick screening of elite controllers
por: Masip, Jenifer, et al.
Publicado: (2021) -
Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
por: Reverté, Laia, et al.
Publicado: (2022) -
Evolution of Serum Acute-Phase Glycoproteins Assessed by (1)H-NMR in HIV Elite Controllers
por: Malo, Ana-Irene, et al.
Publicado: (2021)